Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Buechler C et al. | Adipophilin is a sensitive marker for lipid loading in human blood monocytes. | 2001 | Biochim. Biophys. Acta | pmid:11420178 |
VanderEnde DS and Morrow JD | Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans after the application of cinnamic aldehyde. | 2001 | J. Am. Acad. Dermatol. | pmid:11423836 |
Eto K et al. | Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. | 2001 | Eur. J. Pharmacol. | pmid:11438300 |
Boyault S et al. | 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. | 2001 | FEBS Lett. | pmid:11457450 |
Rovin BH et al. | Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells. | 2001 | J. Am. Soc. Nephrol. | pmid:11461938 |
Cernuda-Morollón E et al. | 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. | 2001 | J. Biol. Chem. | pmid:11466314 |
Hunter JG et al. | Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways. | 2001 | J. Biol. Chem. | pmid:11477074 |
Li L et al. | 15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. | 2001 | J. Biol. Chem. | pmid:11477100 |
Kozawa O et al. | Mechanism of prostaglandin D(2)-stimulated heat shock protein 27 induction in osteoblasts. | 2001 | Cell. Signal. | pmid:11483406 |
Nakashiro KI et al. | Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. | 2001 | Am. J. Pathol. | pmid:11485917 |
Urquhart P et al. | Profile of eicosanoids produced by human saphenous vein endothelial cells and the effect of dietary fatty acids. | 2001 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:11487303 |
Takashima T et al. | PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. | 2001 | Int. J. Oncol. | pmid:11494023 |
Akrishnan VR and Menon VP | Potential role of antioxidants during ethanol-induced changes in the fatty acid composition and arachidonic acid metabolites in male Wistar rats. | 2001 | Cell Biol. Toxicol. | pmid:11504446 |
Chiba Y et al. | PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11511093 |
Nishimura H et al. | Acute effects of prostaglandin D2 to induce airflow obstruction and airway microvascular leakage in guinea pigs: role of thromboxane A2 receptors. | 2001 | Prostaglandins Other Lipid Mediat. | pmid:11519790 |
Clay CE et al. | Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells. | 2001 | J. Investig. Med. | pmid:11523697 |
Monneret G et al. | Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. | 2001 | Blood | pmid:11535533 |
Hughes-Fulford M and Fukushima M | Control of cell cycle by metabolites of prostaglandin D2 through a non-cAMP mediated mechanism. | 1993 | Life Sci Adv Exp Clin Endocrinol | pmid:11539936 |
Ahluwalia P et al. | Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. | 2001 | J. Allergy Clin. Immunol. | pmid:11544467 |
Mizoguchi A et al. | Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11562489 |
Inoue K et al. | Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11563856 |
Jozkowicz A et al. | Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner. | 2001 | Prostaglandins Other Lipid Mediat. | pmid:11577781 |
Yamamoto K et al. | Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. | 2001 | Circulation | pmid:11581147 |
Nielsen PN et al. | Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study. | 2001 | Clin. Exp. Allergy | pmid:11591187 |
Satoh K et al. | Lipid peroxidation end products-responded induction of a preneoplastic marker enzyme glutathione S-transferase P-form (GST-P) in rat liver on admistration via the portal vein. | 2001 | Mutat. Res. | pmid:11600134 |
Masamune A et al. | Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. | 2002 | J. Biol. Chem. | pmid:11606585 |
Clay CE et al. | Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells. | 2001 | J. Biol. Chem. | pmid:11668172 |
Takeda K et al. | 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. | 2001 | J. Biol. Chem. | pmid:11687581 |
Tanaka T et al. | Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. | 2001 | Life Sci. | pmid:11693274 |
Kitatani K et al. | Ceramide accelerates dephosphorylation of extracellular signal-regulated kinase 1/2 to decrease prostaglandin D(2) production in RBL-2H3 cells. | 2001 | Arch. Biochem. Biophys. | pmid:11697858 |
Levonen AL et al. | Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. | 2001 | Arterioscler. Thromb. Vasc. Biol. | pmid:11701476 |
Guan Y et al. | Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. | 2001 | Am. J. Physiol. Renal Physiol. | pmid:11704554 |
Ianaro A et al. | Role of cyclopentenone prostaglandins in rat carrageenin pleurisy. | 2001 | FEBS Lett. | pmid:11707269 |
Azuma Y et al. | 15-Deoxy-delta(12,14)-prostaglandin J2 is a negative regulator of macrophage functions. | 2001 | Int. Immunopharmacol. | pmid:11710539 |
Robbins IM et al. | Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. | 2001 | Chest | pmid:11713147 |
Garcia Palacios V et al. | Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2. | 2001 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:11728175 |
Levine L | Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors. | 2001 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:11728177 |
Tanimoto A et al. | Histamine increases the expression of LOX-1 via H2 receptor in human monocytic THP-1 cells. | 2001 | FEBS Lett. | pmid:11728449 |
Pignatelli M et al. | The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. | 2001 | J. Cell. Sci. | pmid:11739643 |
Gervais FG et al. | Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. | 2001 | J. Allergy Clin. Immunol. | pmid:11742277 |
Simonin MA et al. | PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts. | 2002 | Am. J. Physiol., Cell Physiol. | pmid:11742805 |
Reilly TP et al. | A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. | 2001 | Chem. Res. Toxicol. | pmid:11743745 |
Noverr MC et al. | Production of prostaglandins and leukotrienes by pathogenic fungi. | 2002 | Infect. Immun. | pmid:11748207 |
Schoppee PD et al. | Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. | 2002 | Biol. Reprod. | pmid:11751282 |
Fujitani Y et al. | Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. | 2002 | J. Immunol. | pmid:11751991 |
Yagami T et al. | Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis. | 2002 | Mol. Pharmacol. | pmid:11752212 |
Fu Y et al. | Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages. | 2002 | Atherosclerosis | pmid:11755918 |
Suzuki R and Freed AN | Heparin inhibits hyperventilation-induced late-phase hyperreactivity in dogs. | 2002 | Am. J. Respir. Crit. Care Med. | pmid:11779726 |
Keelan J et al. | 15-deoxy-delta12,14-prostaglandin J2-induced apoptosis in amnion-like WISH cells. | 2001 | Prostaglandins Other Lipid Mediat. | pmid:11785780 |
Shibata T et al. | 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. | 2002 | J. Biol. Chem. | pmid:11786541 |